Literature DB >> 18582925

Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: implications for human disease.

Mio Kirino1, Yohei Kirino, Mitsuhiro Takeno, Yoji Nagashima, Kazuo Takahashi, Masayoshi Kobayashi, Shuji Murakami, Tsutomu Hirasawa, Atsuhisa Ueda, Michiko Aihara, Zenro Ikezawa, Yoshiaki Ishigatsubo.   

Abstract

BACKGROUND: Oxidative stress has been implicated in the exacerbation of atopic dermatitis (AD).
OBJECTIVE: We sought to investigate the pathophysiologic roles of inducible antioxidant heme oxygenase (HO) 1 in the development of AD.
METHODS: Serum HO-1 levels of patients with AD (n = 100) and age-matched healthy control subjects (n = 72) were determined by means of ELISA. The relationships between serum HO-1 levels and clinical severities, laboratory parameters, and cytokines/chemokines were assessed. Skin lesions of patients with AD and psoriasis were analyzed by means of immunohistochemistry. A murine AD model, DS-Nh, was used to further investigate localization and function of HO-1. Evaluation of symptoms, serum IgE and IL-18 levels, immunoblotting results, and histologic analyses of skin were performed. The effect of intraperitoneally administered hemin, a potent HO-1 inducer, or zinc protoporphyrin IX, an inhibitor of HO, was monitored.
RESULTS: Serum HO-1 levels were significantly increased in patients with AD compared with those seen in healthy control subjects and were associated with AD disease severity. Serum HO-1 levels correlated with serum IgE, lactate dehydrogenase, IL-18, and thymus and activation-regulated chemokine levels. HO-1-expressing cells were accumulated in skin lesions of patients with AD and DS-Nh mice. Immunofluorescence of mouse skin lesions revealed that HO-1-positive cells were macrophages and dendritic cells. Treatment with hemin, but not with zinc protoporphyrin IX, attenuated the development of the skin lesions in DS-Nh mice and reduced serum IL-18 levels.
CONCLUSION: HO-1 levels were increased in sera and skin lesions of patients with AD. Enhancement of HO-1 attenuated the development of skin lesions in mice, suggesting that HO-1 induction offers a promising therapeutic strategy for AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582925     DOI: 10.1016/j.jaci.2008.05.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  16 in total

1.  Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo.

Authors:  Yasser E Elassiuty; Jared Klarquist; Jodi Speiser; Randa M Yousef; Abdelaziz A El Refaee; Nahla S Hunter; Olfat G Shaker; Mohan Gundeti; Ludmila Nieuweboer-Krobotova; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2011-03-22       Impact factor: 3.960

2.  Bryonolic acid transcriptional control of anti-inflammatory and antioxidant genes in macrophages in vitro and in vivo.

Authors:  Tonibelle N Gatbonton-Schwager; John J Letterio; Gregory P Tochtrop
Journal:  J Nat Prod       Date:  2012-02-16       Impact factor: 4.050

Review 3.  Heme Oxygenase 1 in Vertebrates: Friend and Foe.

Authors:  Rafael Cardoso Maciel Costa Silva; Leonardo Holanda Travassos Correa
Journal:  Cell Biochem Biophys       Date:  2021-11-20       Impact factor: 2.194

4.  A Role of Staphyococcus aureus, Interleukin-18, Nerve Growth Factor and Semaphorin 3A, an Axon Guidance Molecule, in Pathogenesis and Treatment of Atopic Dermatitis.

Authors:  Zenro Ikezawa; Junko Komori; Yuko Ikezawa; Yusuke Inoue; Mio Kirino; Masako Katsuyama; Michiko Aihara
Journal:  Allergy Asthma Immunol Res       Date:  2010-05-12       Impact factor: 5.764

5.  Manganese superoxide dismutase depletion in murine hematopoietic stem cells perturbs iron homeostasis, globin switching, and epigenetic control in erythrocyte precursor cells.

Authors:  Adam J Case; Joshua M Madsen; David G Motto; David K Meyerholz; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2012-12-05       Impact factor: 7.376

6.  Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions.

Authors:  Takuya Miyazaki; Yohei Kirino; Mitsuhiro Takeno; Maasa Hama; Ayumi Ushihama; Reina Watanabe; Kaoru Takase; Takayoshi Tachibana; Kenji Matsumoto; Masatsugu Tanaka; Satoshi Yamaji; Haruko Ideguchi; Naoto Tomita; Hiroyuki Fujita; Shigeru Ohno; Atsuhisa Ueda; Yoshiaki Ishigatsubo
Journal:  Int J Hematol       Date:  2010-01-22       Impact factor: 2.490

7.  Cell-penetrating heme oxygenase-1 in the therapy of atopic dermatitis in mice.

Authors:  Fang Tang; Xueqing Ma; Jiayu Sun; Minghui Ru; Tiansheng Qian; Wengjing Ji; Sifan Qian; Hua Li
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

8.  Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus.

Authors:  Wei Bao; Fangfang Song; Xiangyang Li; Shuang Rong; Wei Yang; Muxun Zhang; Ping Yao; Liping Hao; Nianhong Yang; Frank B Hu; Liegang Liu
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

9.  Heme oxygenase-1: its therapeutic roles in inflammatory diseases.

Authors:  Hyun-Ock Pae; Hun-Taeg Chung
Journal:  Immune Netw       Date:  2009-02-28       Impact factor: 6.303

10.  Curcumin ameliorates TNF-α-induced ICAM-1 expression and subsequent THP-1 adhesiveness via the induction of heme oxygenase-1 in the HaCaT cells.

Authors:  Gi Soo Youn; Dong-Joo Kwon; Sung Mi Ju; Soo Young Choi; Jinseu Park
Journal:  BMB Rep       Date:  2013-08       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.